AVENUE THERAPEUTICS, INC. (ATXI)

Every figure this model derived for ATXI, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 6,942,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 3,960,000 AssetsCurrent 2021-12-31
current liabilities 1,407,000 LiabilitiesCurrent 2026-06-30
equity 569,000 StockholdersEquity 2026-06-30
ocf -1,384,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 1,404,000 Revenues 2025-12-31
sbc 427,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up ATXI on one particular measure came for.

RatioValue
cash operating margin-175.93
current ratio2.81
current ratio reported2.81
dilution pct141.89
fcf margin-98.58
operating margin-206.34
owner earnings margin-128.99
sbc pct revenue30.41

What to be careful about

What this model itself distrusts about ATXI's figures. Written by the derivation as it ran, not added afterwards.